EKF Diagnostics is a leading manufacturer of point-of-care diagnostics and central laboratory testing, with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose, and lactate analysis instruments regularly used in over 100 countries.

EKF Diagnostics specializes in developing tests for use in the diagnosis and management of diabetes and anemia, while also providing a portfolio of reagents for use in clinical chemistry analysis.

During the COVID-19 pandemic, EKF Diagnostics has developed and expanded its contract manufacturing capabilities in three countries to be able to provide a comprehensive range of services to third-party customers.